验证数据展示
经过测试的应用
Positive IF/ICC detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL594-67187 targets ENO1 in IF/ICC applications and shows reactivity with human, mouse, rat, pig samples.
经测试应用 | IF/ICC Application Description |
经测试反应性 | human, mouse, rat, pig |
免疫原 | ENO1 fusion protein Ag17518 种属同源性预测 |
宿主/亚型 | Mouse / IgM |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | enolase 1, (alpha) |
别名 | ENO1L1, EC:4.2.1.11, C-myc promoter-binding protein, Alpha-enolase, 2-phospho-D-glycerate hydro-lyase |
计算分子量 | 47 kDa |
观测分子量 | 47 kDa |
GenBank蛋白编号 | BC015641 |
基因名称 | ENO1 |
Gene ID (NCBI) | 2023 |
ENSEMBL Gene ID | ENSG00000074800 |
RRID | AB_2920094 |
偶联类型 | CoraLite®594 Fluorescent Dye |
最大激发/发射波长 | 588 nm / 604 nm |
形式 | Liquid |
纯化方式 | Thiophilic affinity chromatograph |
UNIPROT ID | P06733 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
ENO1, also named as NNE, ENO1L1, MBPB1, MPB1 and MBP1, belongs to the enolase family. ENO1 is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and mediates the activation of plasmin and extracellular matrix degradation. In tumor cells, ENO1 is up-regulated and supports the Warburg effect; it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. ENO1 overexpression and post-translational modifications could be of diagnostic and prognostic value in many cancer types. (PMID: 27814656)
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL594 ENO1 antibody CL594-67187 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |